Work

Combination of zanubrutinib (zanu) + venetoclax (ven) for treatment-naive (TN) CLL/SLL: Results in SEQUOIA arm D.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.7009

Authors: Mazyar Shadman, Talha Munir, Shuo Ma, Masa Lasica, Monica Tani, Tadeusz Robak, Ian W. Flinn, Jennifer R. Brown, Paolo Ghia, Emmanuelle Ferrant, Constantine Si Lun Tam, Wojciech Janowski, Wojciech Jurczak, Linlin Xu, Tian Tian, Stephanie Agresti, Jamie Hirata, Alessandra Tedeschi

Institutions: University of Washington, Fred Hutch Cancer Center, Leeds Teaching Hospitals NHS Trust, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, St Vincent's Hospital Melbourne, Ospedale "Santa Maria delle Croci" di Ravenna, Copernicus Memorial Hospital, Medical University of Lodz, Tennessee Oncology, Dana-Farber Cancer Institute, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Hôpital Lyon Sud, The Alfred Hospital, Monash University, Calvary Mater Newcastle Hospital, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: BeiGene

OpenAlex ID: W4410818847

Cites:

Cited by:

Related to: 10